Home LiteratureArticle Details
该文献已被撤稿(Retracted Publication),引用前请核实。
PMID: 7545174 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Retracted Publication

Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line.

The Journal of biological chemistry ·Vol. 270 ·No. 37 ·1995-00-15 ·Pages 21998-2007

Aronica SM, Mantel C, Gonin R, Marshall MS, Sarris A, Cooper S, Hague N, Zhang XF, Broxmeyer HE

Abstract

Stimulatory cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF) and steel factor (SLF), act in a synergistic manner to stimulate the growth of hematopoietic progenitor cells, an effect also demonstrated for the growth factor-dependent human hematopoietic cell line MO7e. While little is known about the mechanisms responsible for mediating synergistic interactions of cytokines, Raf-1, a component of the MAP kinase signaling pathway, is thought to play a role in the stimulatory response evoked by several cytokines, including SLF and GM-CSF. Interferon-inducible protein-10 (IP-10) and macrophage inflammatory protein-1 alpha (MIP-1 alpha) are members of the chemokine family of suppressive cytokines. Prior exposure of hematopoietic cells to chemokines, including IP-10 and MIP-1 alpha, inhibits the synergistic action of growth factors on stimulating cell proliferation. We report that treatment of MO7e cells with the combination of GM-CSF and SLF directly stimulates statistically significant synergistic increases in the phosphorylation and activation of Raf-1 kinase, and in cellular protein synthesis levels. Pretreatment of MO7e cells with IP-10 or MIP-1 alpha blocked synergistic growth factor action, resulting in statistically significant suppression of cell proliferation, protein synthesis, and Raf-1 phosphorylation and activation. IP-10 and MIP-1 alpha treatment also evoked significant increases in intracellular cAMP levels. Pretreatment of cells with agents which serve to raise intracellular cAMP levels, or with cAMP analogs inhibited the synergistic actions of GM-CSF and SLF in a manner similar to IP-10 and MIP-1 alpha. In addition, treatment of cells with a potent inhibitor of cAMP-dependent protein kinase A blocked the suppressive action of MIP-1 alpha and IP-10 on Raf-1 kinase activity and on MO7e cell proliferation. The ability of IP-10 and MIP-1 alpha to antagonize the synergistic action of GM-CSF and SLF appears to involve inactivation of Raf-1 and the down-regulation of protein synthesis. Our findings suggest that both MIP-1 alpha and IP-10 mediate their suppressive effects in MO7e cells by stimulating increases in cellular cAMP levels and activating protein kinase A, a mechanism we believe to be unique to these chemokines and not one applied to all growth suppressive members of the chemokine superfamily (for example, interleukin 8 and platelet factor 4).

MeSH Terms
Cell Line Chemokine CCL4 Chemokine CXCL10 Chemokines, CXC Colony-Forming Units Assay Cycloheximide/pharmacology Cytokines/pharmacology Drug Synergism Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology Growth Inhibitors/pharmacology Growth Substances/pharmacology Hematopoietic Cell Growth Factors/pharmacology Hematopoietic Stem Cells Humans Kinetics Leucine/metabolism Macrophage Inflammatory Proteins Monokines/pharmacology Protein Biosynthesis Protein Serine-Threonine Kinases/antagonists & inhibitors,metabolism Proto-Oncogene Proteins/antagonists & inhibitors,metabolism Proto-Oncogene Proteins c-raf Recombinant Proteins/pharmacology Stem Cell Factor Time Factors
Chemicals
Chemokine CCL4 Chemokine CXCL10 Chemokines, CXC Cytokines Growth Inhibitors Growth Substances Hematopoietic Cell Growth Factors Macrophage Inflammatory Proteins Monokines Proto-Oncogene Proteins Recombinant Proteins Stem Cell Factor Granulocyte-Macrophage Colony-Stimulating Factor Cycloheximide Protein Serine-Threonine Kinases Proto-Oncogene Proteins c-raf Leucine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Aronica S M
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202, USA.
Mantel C
Gonin R
Marshall M S
Sarris A
Cooper S
Hague N
Zhang X F
Broxmeyer H E
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1995-00-15
Pages
21998-2007
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NHLBI NIH HHS · R01HL46549 · United States
NHLBI NIH HHS · R01HL49202 · United States
NCI NIH HHS · R37CA36464 · United States
Corrections
CommentIn
RetractionIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]